Showing 9,721 - 9,740 results of 74,781 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.28s Refine Results
  1. 9721

    THS exposure in conjunction with antioxidant treatment for 2.5 and 5 months alleviates metabolic syndrome in a dose-dependent manner. by Neema Adhami (516427)

    Published 2016
    “…Antioxidant+THS treated mice had reduced fasting blood glucose levels <b>(B)</b>, decreased fasting insulin levels <b>(C)</b>, greatly restored protein levels in insulin signaling proteins IR, PI3K and AKT <b>(D-F)</b>, and lower HOMA-IR index (fasting blood glucose X Fasting insulin/22.5) <b>(G)</b>. …”
  2. 9722

    Fig 6 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  3. 9723

    Fig 2 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  4. 9724

    Fig 1 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  5. 9725

    Participant traits. by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  6. 9726

    Fig 4 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  7. 9727

    Fig 3 - by Matthew C. Kochem (18476069)

    Published 2024
    “…Plasma glucose, insulin, and glucagon were measured before, during, and after OGTTs up to 120 minutes post-prandially. We also assessed individual participants’ sweet taste responses to sucralose and their sensitivities to lactisole sweetness inhibition. …”
  8. 9728
  9. 9729

    ERK5-RNA interference suppresses MCF-7-MEK5 tumor growth and restores ER-α protein expression. by James W. Antoon (444010)

    Published 2013
    “…Decreased expression of ERK5 was confirmed with (A) RT-PCR and (B) western blot analysis. …”
  10. 9730

    Identification of Adenylate Kinase 5 as a Protein Target of Ginsenosides in Brain Tissues Using Mass Spectrometry-Based Drug Affinity Responsive Target Stability (DARTS) and Cellul... by Feiyan Chen (775268)

    Published 2022
    “…Then, we identified and confirmed adenylate kinase 5 (AK5) as a target protein of ginsenosides by biolayer interferometry (BLI), isothermal titration calorimetry (ITC), and molecular docking. …”
  11. 9731

    Identification of Adenylate Kinase 5 as a Protein Target of Ginsenosides in Brain Tissues Using Mass Spectrometry-Based Drug Affinity Responsive Target Stability (DARTS) and Cellul... by Feiyan Chen (775268)

    Published 2022
    “…Then, we identified and confirmed adenylate kinase 5 (AK5) as a target protein of ginsenosides by biolayer interferometry (BLI), isothermal titration calorimetry (ITC), and molecular docking. …”
  12. 9732
  13. 9733

    The Synergistic Roles of Cholecystokinin B and Dopamine D<sub>5</sub> Receptors on the Regulation of Renal Sodium Excretion by Xiaoliang Jiang (845022)

    Published 2016
    “…Hence, we sought to investigate the interaction between D<sub>5</sub>R and CCK<sub>B</sub>R in the regulation of renal sodium excretion. …”
  14. 9734
  15. 9735
  16. 9736

    Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study by Jilles M. Fermont (3746068)

    Published 2020
    “…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”
  17. 9737
  18. 9738
  19. 9739
  20. 9740

    CD5-CK2 Signaling Modulates Erk Activation and Thymocyte Survival by Carlos A. Mier-Aguilar (3605360)

    Published 2016
    “…Using a gene-targeted mouse in which the CD5-CK2BD is selectively ablated (CD5-ΔCK2BD), we determined that loss of function of CD5-CK2 signaling in a MHC-II selecting TCR transgenic (OT-II) mouse resulted in decrease in double positive (DP) thymocytes, which correlated with enhanced apoptosis. …”